Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

Keyphrases

• Tumor 100%
• Molecular Genetic Analysis 100%
• Oligodendroglial Tumors 100%
• Allelic Loss 42%
• Genetic Modification 28%
• Molecular Genetics 28%
• Tumor Protein p53 (TP53) 28%
• Loss of Heterozygosity 28%
• Anaplastic 28%
• Anaplastic Oligodendroglioma 28%
• Anaplastic Oligoastrocytoma 28%
• Mixed Glioma 28%
• Central Nervous System 14%
• Increased Incidence 14%
• Oncogenesis 14%
• Early Events 14%
• Tumor Suppressor Gene 14%
• Renin 14%
• TP53 mutation 14%
• Common Pathway 14%
• Gene Locus 14%
• Gene Amplification 14%
• Chromosome 10 14%
• Epidermal Growth Factor Receptor Gene 14%
• Restriction Fragment Length Polymorphism 14%
• Polymorphic Loci 14%
• Exon 2 14%
• Oligodendroglioma 14%
• Oligoastrocytoma 14%
• Astrocytic Tumor 14%
• Chromosome 9p 14%
• 1p13 14%
• Astrocyte Differentiation 14%
• Oligodendroglial Differentiation 14%

Biochemistry, Genetics and Molecular Biology

• Molecular Genetics 100%
• Allele 100%
• Loss of Heterozygosity 66%
• Gene Mutation 66%
• Genetics 33%
• Exon 33%
• Receptor Gene 33%
• Tumor Suppressor Gene 33%
• Gene Amplification 33%
• Gene Locus 33%
• Chromosome 10 33%
• Restriction Fragment Length Polymorphism 33%
• Polymorphic Locus 33%
• Chromosome 9p 33%
• Carcinogenesis 33%
• Epidermal Growth Factor Receptor 33%
• Renin 33%

Neuroscience

• Oligodendroglioma 100%
• TP53 100%
• Gene Mutation 66%
• Central Nervous System 33%
• Renin 33%
• Receptor Gene 33%
• Gene Locus 33%
• Tumor Suppressor Gene 33%
• Chromosome 10 33%
• Gene Amplification 33%
• Polymorphic Locus 33%
• Chromosome 9p 33%
• Restriction Fragment Length Polymorphism 33%
• Carcinogenesis 33%
• Exon 33%
• Epidermal Growth Factor Receptor 33%